Ovation Science Inc.
OVAT
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 12.00K | 12.20K | 11.50K | 10.60K | 30.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.00K | 12.20K | 11.50K | 10.60K | 30.90K |
| Cost of Revenue | 0.00 | 300.00 | 2.30K | 2.00K | 800.00 |
| Gross Profit | 12.00K | 11.90K | 9.20K | 8.60K | 30.10K |
| SG&A Expenses | 101.20K | 86.80K | 68.40K | 90.10K | 123.10K |
| Depreciation & Amortization | -- | -- | 0.00 | 400.00 | 600.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 101.20K | 87.10K | 71.60K | 92.80K | 126.00K |
| Operating Income | -89.20K | -74.90K | -60.10K | -82.20K | -95.20K |
| Income Before Tax | -96.50K | -84.70K | -18.80K | -130.60K | -55.40K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -96.50K | -84.70K | -18.80K | -130.60K | -55.40K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -96.50K | -84.70K | -18.80K | -130.60K | -55.40K |
| EBIT | -89.20K | -74.90K | -60.10K | -82.20K | -95.20K |
| EBITDA | -88.80K | -74.50K | -59.70K | -81.80K | -94.60K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 34.98M | 34.98M | 35.25M | 35.24M | 29.37M |
| Average Diluted Shares Outstanding | 34.98M | 34.98M | 35.25M | 35.24M | 29.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |